Yield10 Bioscience(YTEN) - 2023 Q4 - Annual Results

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results -Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market -Advanced regulatory and seed scale-up program for omega-3 Camelina -E3902 oil trait in Camelina cleared by regulatory authority for planting in Canada -Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update "In early 2024, Yield10 granted to Vision Bioenergy Oilsee ...